Cellular therapy and regenerative medicine (10)
All Items
-
Chimeric antigen receptor therapy for hematological malignancies: a pediatric perspective from leukapheresis to infusion: CAR T cell therapy for pediatric hematologic malignancies
-
Effectiveness of oral platelet lysate gel to treat oral mucosal manifestations associated with chronic graft versus host disease: PL gel for oral cGvHD: efficacy and safety
-
First use of cord blood platelet-rich plasma in the treatment of vulvar lichen sclerosus: a preliminary study towards a randomized controlled trial: Cord blood platelet rich plasma in vulvar lichen sclerosus
-
In vitro regenerative effects of a pooled pathogen-reduced lyophilized human cord blood platelet lysate for wound healing applications: Human cord blood platelet lysate for wound healing applications
-
Platelet rich plasma for assisted reproduction: an overview of systematic reviews: PRP for assisted reproduction
-
Platelet rich plasma for facial rejuvenation: an overview of systematic reviews: PRP for facial rejuvenation
-
Platelet rich plasma use for treatment of acne scars: an overview of systematic reviews: PRP for acne scars
-
Platelet-rich plasma for the treatment of alopecia: a systematic review and meta-analysis: PRP for treatment of alopecia
-
The tandem CD33-CLL1 CAR-T as an approach to treat acute myeloid leukemia: The tandem CLL1/CD33 CAR-T to treat AML
-
Ultrasound-guided injection of platelet-rich plasma for tendinopathies: a systematic review and meta-analysis
10 Items
Announcements
Winter Closure
The Editorial Office will be closed from December 31 to January 7, 2026.
Season’s greetings to all our readers, authors, and reviewers.
Read moreSIMTI 2026
46° Convegno Nazionale di Studi di Medicina Trasfusionale - Abstract Book (in Italian)
Read moreSETS 2026
35° Congreso de la Sociedad Española de Transfusión Sanguínea y Terapia Celular - SETS - Abstract Book (in Spanish), is online (https://www.bloodtransfusion.it/bt/issue/view/81).Madrid, 4-6 June 2026.
Read moreEditorial Office Closure Notice
Please note that the BT Editorial Office will be closed until August 26, 2026.
During this period, responses to inquiries and the processing of manuscripts may be delayed. All editorial activities will resume as usual after this date.
Thank you for your understanding.
Best regards,
BT Editorial Office
Read more
Impact Factor 2025
We are pleased to announce that Blood Transfusion has achieved a 2025 Impact Factor of 2.7.
Read more